I understand your point Steph thanks for calling it out. I put my thoughts out there on this board because I care about the work BBIO is doing and and I want to be invested here. This still can be the best horse in the race. I don't criticize on the more well read other board btw, I know some of the team read this one. I've made suggestions to Benz in the past that have yielded results the next day. I think there's a place for Jan and Art at the new company for sure, they seem to have started this after all, and it's their company in many ways. There's something called the Peter Principle, which is.. People rise to the level of their own Incompetence. I'd like to see Art be rewarded with a VP of M&A role, with some rules about who needs to sign off...Benz. I know you have close relationships and I appreciate you reminding me of the good work this company is doing in real life. I'll exhale if the merger goes through on time without drama and if BBIO revenues get to live within SKTO. Otherwise, sadly for me, I may have to wish you all luck, move on and call it a fun year. *dear mgmt! please address the AVNE situation and whether we are splitting BBIO revenue with a now defunct and botched shell deal* this is a fair question. The licensing is where the profit is right? I think we gave it away.
I understand your point Steph thanks for calling it out. I
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Cloud Software Group Amends $2B Cash Tender Offer
Cloud Software Group is stirring the pot with an amendment that'll have bondholders looking twice at their portfolios. On November 3, 2026, the company announced a tweak to its cash tender offer, bumping up the payment for its 9.00% Senior Secured Second Lien Notes due 2029. The payout now jumps from $1,017.50 to $1,022.50 for each $1,000 of principal. If you're holding...
Continue Reading
ACLM and eClinicalWorks Expand Lifestyle Medicine Reach
Changing the Game with Lifestyle Medicine When it comes to healthcare, you're always going to have the skeptics grousing about the old ways. But what happens when you take an old idea and turbocharge it with modern tech? That's where the American College of Lifestyle Medicine (ACLM) and eClinicalWorks step in. They’re throwing a new wrench into the electronic health...
Continue Reading
STVN's GLP-1 Fumble Sparks Shareholder Scrutiny
The Storm Hits Stevanato: GLP-1 Blues Well, ain't this a fine pickle for Stevanato Group S.p.A. (NYSE:STVN). November 3, 2026, turned into quite the ride for those holding STVN shares. A tough third-quarter report dropped like a ton of bricks, driving the shares down after they coughed up a lower outlook for GLP-1 volumes in 2027. If you've been in the game long enough,...
Continue Reading
Tamagotchi Turns 30: Roblox Event Connects Worlds
A New Chapter for an Old Favorite Dust off your digital pets, folks! Tamagotchi is not just a thing of the past. It's busting out of its shell to celebrate a big 3-0 with a splash—and get this—on Roblox. Who would've thought a plastic egg with pixels would still be out there thriving in the ether of childhood nostalgia three decades later? But it is, and it’s taking...
Continue Reading
ROBOTWORLD 2026: AI Reshapes Industrial Horizons
A Grand Gathering of Robotics Minds Walking into KINTEX, Seoul's suburban behemoth of an exhibition center, you'll find a buzz that rivals the excitement of a stock floor on earnings day. It's ROBOTWORLD 2026, a stage set for tech titans and ambitious startups alike, all throwing in their chips on AI and robotics. From November 4th to 7th, 402 companies hailing from 17...
Continue Reading
3M's Huge Settlement: Navigating A Looming Legal Fog
The latest chapter in 3M’s legal saga reads like a courtroom drama, but this time, the company's shelling out big bucks to sidestep prolonged courtroom battles. They're committing to a $5.8 billion payout over several years, aiming to put a lid on a massive batch of PFAS-related lawsuits. It’s like they’re cleaning the spill with a velvet mop, but the trick is...
Continue Reading
DarioHealth Taps Palumbo to Drive Healthcare Evolution
Strategic Leadership for an Evolving Market Prepare your portfolios, folks. DarioHealth Corp. (NASDAQ:DRIO) is gearing up to ride a seismic shift in healthcare. John R. Palumbo's appointment as Chairman of the Board marks a bold move as Dario looks to dominate the new convergence of consumer-directed and payer-funded healthcare. This isn't just a change of guard; it's a...
Continue Reading
VAB's Pharma Ad Guide: Emerging Trends and Insights
Pharma's not just popping pills anymore; it's a whole show on multiscreen TV. The Video Advertising Bureau (VAB) just dropped a bombshell of a guide called The Pharmacy, diving into the state of pharmaceutical direct-to-consumer (DTC) advertising. Over the past year and a half, VAB's been grilling agencies, media folks, and anyone else with skin in the game to sketch the...
Continue Reading
SWFI's I20 Summit Spotlights 3,000 Promising Start-Ups
Spotlight on Emerging Titans: The Future 100 Watchlist The Sovereign Wealth Fund Institute is rattling the investment cages with their latest stunt, the 'Future 100 Watchlist.' Hot off the press, this list is parading nearly 3,000 start-ups that are biting at the heels of future success. It's high stakes and higher hopes between December 11-16 at Miami's I20 Summit, where...
Continue Reading
Compass Faces Securities Fraud Suit: Deadline Looms
Compass's Legal Rumble: Shareholders Take Note You know there’s trouble when a firm’s every effort at glassy-eyed optimism is slapped with a lawsuit. We've seen this song and dance far too often, and now Compass, Inc. (NYSE: COMP) takes center stage. Schall, Brown & Schwartz LLP is rallying the troops for a knock-down-drag-out class action lawsuit, accusing Compass of...
Continue Reading
